Skip to content

A Randomized Controlled Study for the Treatment of Middle-aged and Old-aged Lumbar Disc Herniation by Shi's Spine Balance Manipulation Combined with Bone and Muscle Guidance

A Randomized Controlled Study for the Treatment of Middle-aged and Old-aged Lumbar Disc Herniation by Shi's Spine Balance Manipulation Combined with Bone and Muscle Guidance

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021825
Enrollment
Unknown
Registered
2019-03-11
Start date
2019-03-15
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

Treatment group:Shi's Spine Balance Manipulation Combined with Bone and Muscle Guidance
Control group:Pelvic traction

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Informed consent and signing of informed consent form; 2. Patients meeting diagnostic criteria; 3. Men or women aged 40-75; 4. The course of disease is longer than 3 months; 5. Willingly accept the spinal balance manipulations and tendon and bone guiding training required for cooperation.

Exclusion criteria

Exclusion criteria: 1. Have participated in or are participating in other clinical researchers in the past 3 months; 2. Those who have failed to receive formal non-surgical therapy for 6 months and whose symptoms have worsened; 3. The muscle strength decreased obviously in a short period of time. The muscle strength was less than Grade III, and the symptoms of cauda equina compression were found. 4. Imaging diagnosis for prolapse of intervertebral disc completely protruding; 5. Those with severe lumbar trauma and lumbar surgery history; 6. Pregnant or pregnant women; 7. Those who have a history of opioid analgesics, sedative hypnotics and alcohol abuse; 8. Patients with severe primary diseases such as liver, kidney, hematopoietic system, endocrine system, cardiovascular and cerebrovascular diseases, nervous system, tuberculosis, vertebral body malformation, malignant tumor and psychosis; 9. Those who do not read or write Chinese.

Design outcomes

Primary

MeasureTime frame
VAS;Pain threshold;Lumbar dysfunction index;

Countries

China

Contacts

Public ContactJinhai xu

Longhua Hospital Affiliated to Shanghai University

jinhaixu@126.com+86 18016006692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026